Cerexin D4
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Antibiotics |
| Catalog number | BBF-00520 |
| CAS | 70943-88-3 |
| Molecular Weight | 1376.60 |
| Molecular Formula | C66H101N15O17 |
Online Inquiry
Description
It is produced by the strain of Bac.cereus Gp-3. It has anti-gram-positive bacterial activity.
Specification
| IUPAC Name | (2R,3S)-2-[[(2R)-2-[[2-[[(2R,3R)-2-[[(2S)-6-amino-2-[[(2R)-4-amino-2-[[(2S)-4-amino-2-[[(2R)-2-[[(2R)-2-[[(2R)-4-amino-2-[(3-hydroxy-9-methyldecanoyl)amino]-4-oxobutanoyl]amino]-3-methylbutanoyl]amino]-3-phenylpropanoyl]amino]-4-oxobutanoyl]amino]-4-oxobutanoyl]amino]hexanoyl]amino]-3-hydroxybutanoyl]amino]acetyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoic acid |
| Canonical SMILES | CCC(C)C(C(=O)O)NC(=O)C(CC1=CNC2=CC=CC=C21)NC(=O)CNC(=O)C(C(C)O)NC(=O)C(CCCCN)NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)N)NC(=O)C(CC3=CC=CC=C3)NC(=O)C(C(C)C)NC(=O)C(CC(=O)N)NC(=O)CC(CCCCCC(C)C)O |
| InChI | InChI=1S/C66H101N15O17/c1-8-37(6)56(66(97)98)80-62(93)46(28-40-33-71-43-24-16-15-23-42(40)43)74-54(88)34-72-64(95)57(38(7)82)81-58(89)44(25-17-18-26-67)75-60(91)48(31-51(69)85)77-61(92)49(32-52(70)86)76-59(90)45(27-39-20-12-10-13-21-39)78-65(96)55(36(4)5)79-63(94)47(30-50(68)84)73-53(87)29-41(83)22-14-9-11-19-35(2)3/h10,12-13,15-16,20-21,23-24,33,35-38,41,44-49,55-57,71,82-83H,8-9,11,14,17-19,22,25-32,34,67H2,1-7H3,(H2,68,84)(H2,69,85)(H2,70,86)(H,72,95)(H,73,87)(H,74,88)(H,75,91)(H,76,90)(H,77,92)(H,78,96)(H,79,94)(H,80,93)(H,81,89)(H,97,98)/t37-,38+,41?,44-,45+,46+,47+,48+,49-,55+,56+,57+/m0/s1 |
| InChI Key | MKGCAZKSZKRUSC-DSGIVJFFSA-N |
Properties
| Antibiotic Activity Spectrum | Gram-positive bacteria |
Reference Reading
1. Resolution of peptide antibiotics, cerexins and tridecaptins, by high performance liquid chromatography (studies on antibiotics from the genus Bacillus. XXVI)
J Shoji, T Kato, S Terabe, R Konaka J Antibiot (Tokyo). 1979 Apr;32(4):313-9. doi: 10.7164/antibiotics.32.313.
By high performance liquid chromatography, cerexin B was separated into four components (B1, B2, B3 and B4), cerexin D into four components (D1, D2, D3 and D4), tridecaptin A into components (A alpha and A beta), tridecaptin B into four components (B alpha, B beta, B gamma and B delta) and tridecaptin C into three components (C alpha 1, C alpha 2 and C beta 1). All components were preparatively isolated, and their fatty acid and amino acid compositions determined for structural elucidation.
Recommended Products
| BBF-01826 | Deoxymannojirimycin | Inquiry |
| BBF-02642 | Lactonamycin | Inquiry |
| BBF-01825 | Loganin | Inquiry |
| BBF-02614 | Nystatin | Inquiry |
| BBF-01693 | Doxorubicin EP Impurity A (Daunorubicin) | Inquiry |
| BBF-03755 | Actinomycin D | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
* Total Molecular Weight:
g/mol
Tip: Chemical formula is case sensitive. C22H30N4O √ c22h30n40 ╳
